This study examined the effects of either medical therapy alone (angiotensin receptor blockers or angiotensin-converting enzyme inhibitors) or the combination of medical therapy with percutaneous transluminal renal angioplasty on renal ADC in patients with renal vascular disease [45]. This evidence concerns the gene ACE and renal artery disease.